70 results
424B5
SLNO
Soleno Therapeutics Inc
6 May 24
Prospectus supplement for primary offering
4:58pm
management, investment research, principal investment, hedging, financing and brokerage activities. The underwriters and certain of their respective
424B5
SLNO
Soleno Therapeutics Inc
2 May 24
Prospectus supplement for primary offering
4:04pm
, hedging, financing and brokerage activities. The underwriters and certain of their respective affiliates have, from time to time, performed, and may
8-K
EX-10.1
3315u4xb1i
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
424B5
kr96w4 5pv
29 Sep 23
Prospectus supplement for primary offering
4:51pm
424B5
bxwm1crh62c91549ia2t
27 Sep 23
Prospectus supplement for primary offering
5:26pm
8-K
EX-10.1
bcs9 pibsfhsegv7j
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm